Sandoz’s Saynor Reflects On Industry Challenges

Discusses Issues Including Shortages, PBMs In The US And The UK’s VPAS Rebate

 
• By Dave Wallace

In the third and final part of his exclusive interview with Generics Bulletin, Sandoz CEO Richard Saynor discusses global off-patent industry challenges including antibiotics shortages, PBM behavior in the US and the UK’s VPAS rebate mechanism.

Large yellow arrow facing multiple small white arrows in opposite direction
The generics industry is facing multiple challenges • Source: Shutterstock

More from Regulation

More from Policy & Regulation